Featured Research

from universities, journals, and other organizations

Antacids Are As Effective As Surgery For Treating Severe Heartburn, UT Southwestern Physician Shows

Date:
May 9, 2001
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
Many Americans suffer heartburn, but for some it's more frequent and serious. A new study by a UT Southwestern Medical Center at Dallas physician, published in the Journal of the American Medical Association, suggests that anti-reflux surgery is no better for treating severe heartburn than antacid medications.

DALLAS - May 9, 2001 - Many Americans suffer heartburn, but for some it's more frequent and serious. A new study by a UT Southwestern Medical Center at Dallas physician, published in today's Journal of the American Medical Association, suggests that anti-reflux surgery is no better for treating severe heartburn than antacid medications.

Dr. Stuart Spechler, chief of gastroenterology at the Dallas Veterans Affairs Medical Center and vice chief of digestive and liver diseases at UT Southwestern, and his colleagues conducted a follow-up study of patients who had been treated 10 years earlier for gastroesophageal reflux disease, or GERD, to determine whether those who had surgery for the disease fared better than those who took prescription medication.

While the majority of patients were satisfied with whatever treatment they had received, the researchers were surprised to find two-thirds of the surgery patients still took anti-reflux medication regularly. The surgery patients had similar rates of developing esophageal strictures (narrowing of the esophagus from scarring) as patients who received medical therapy, and there was no significant difference between the groups in the development of esophageal cancer, both complications of severe GERD.

GERD is caused when a faulty valve at the lower end of the esophagus allows reflux, stomach acid flowing back into the food pipe, to occur. This acid can cause heartburn, irritate the voice and trigger chronic coughing. Approximately 20 percent of U.S. adults experience GERD symptoms at least once a week. Severe GERD burns ulcers in the lining of the esophagus and increases the risk of the usually fatal esophageal cancer. Treatment involves either surgery to repair the valve or prescription medication to reduce stomach-acid production.

Spechler and his team found 239 of the original 247 patients who took part in a 1986- 1988 VA study of medical and surgical anti-reflux treatments. By the time of the follow-up in October 1997, 79 patients had died. Among the survivors, 129 (91 in the medical-treatment group and 38 in the surgical-treatment group) took part in the follow-up.

For reasons still unclear, the surgical patients were more likely to have died from heart disease.

"Patients who are going to have an operation should consider very carefully their reasons for having the surgery. If they believe that surgery will allow them to never again take medicine for the treatment of reflux disease or that they are preventing a cancer of the esophagus, this study does not support either of these contentions," Spechler said.

A complication of GERD called Barrett esophagus is a strong risk factor for esophageal cancer, a malignancy that has dramatically increased over the past 20 years. Barrett esophagus is a complication in which intestinal-type lining cells are found in the esophagus. In this study, patients who had Barrett esophagus developed esophageal cancer at a rate of 0.4 percent per year, compared to 0.07 percent in those without Barrett esophagus.

"The findings of this study are interesting, and I would agree that patients must carefully weigh the risks and benefits of medical and surgical treatment before they choose a course of treatment," said Dr. Robert Rege, chairman of surgery at UT Southwestern.

"However, surgery remains an effective treatment for patients with GERD especially if they fail medical therapy. The data presented by Dr. Spechler may help us to decide which patients are best treated with medicine or surgery," Rege said.

Also participating in this research from UT Southwestern was Dr. Edward Lee, professor of pathology and chief of the pathology service at the Dallas VA. Other researchers from VA medical centers in Denver; West Roxbury, Mass.; Phoenix; Little Rock, Ark.; Tucson, Ariz.; Hines, Ill.; Richmond, Va.; Omaha, Neb.; and Perry Point, Md., also contributed to the study.

The study was supported by grants from the Department of Veterans Affairs Medical Research Service Cooperative Studies Program and Ethicon Endo-Surgery in Cincinnati.


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "Antacids Are As Effective As Surgery For Treating Severe Heartburn, UT Southwestern Physician Shows." ScienceDaily. ScienceDaily, 9 May 2001. <www.sciencedaily.com/releases/2001/05/010509082917.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2001, May 9). Antacids Are As Effective As Surgery For Treating Severe Heartburn, UT Southwestern Physician Shows. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/05/010509082917.htm
University Of Texas Southwestern Medical Center At Dallas. "Antacids Are As Effective As Surgery For Treating Severe Heartburn, UT Southwestern Physician Shows." ScienceDaily. www.sciencedaily.com/releases/2001/05/010509082917.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins